Offering Avastin for wet AMD is legal, says appeal court
The Court of Appeal has ruled unanimously that a policy of offering bevacizumab (Avastin) off label to NHS patients with wet age-related macular degeneration (AMD) as an alternative to the much more…
Read Original Article: Offering Avastin for wet AMD is legal, says appeal court »
